Filing Flows › Korsana Biosciences (KRSA) › Q4 2025 › vs Q3 2025
Korsana Biosciences (KRSA) Q4 2025 vs Q3 2025 (quarter over quarter)
Korsana Biosciences's revenue rose $150K (+17%) from $875K in Q3 2025 to $1.0M in Q4 2025.
Korsana Biosciences, Q4 2025: revenue $1.0M (-43% year over year), operating margin -81.8%, net loss $799K, operating cash flow −$1.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q4 2025 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $875K | $150K | +17% |
| Other income, net | $39K | $30K | $9K | +30% |
| Net loss | $799K | $976K | −$177K | -18% |
| Costs & expenses | $1.9M | $1.9M | −$18K | -1% |
| Operating costs | $1.9M | $1.9M | −$18K | -1% |
| Research & development | $519K | $348K | $171K | +49% |
| General & admin | $1.3M | $1.5M | −$189K | -12% |
| Operating cash sources | $1.7M | $382K | $1.3M | +338% |
| Share-based compensation | $95K | $118K | −$23K | -19% |
| Cash used in operations | $1.6M | $264K | $1.3M | +498% |
| Net loss absorbed | $799K | $976K | −$177K | -18% |
| Working capital & other | $875K | −$594K | $1.5M | — |
Questions
How much did Korsana Biosciences's revenue grow quarter over quarter in Q4 2025?
Korsana Biosciences's revenue rose $150K (+17%) from $875K in Q3 2025 to $1.0M in Q4 2025.